Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Dec 19, 2023

SELL
$191.51 - $216.16 $1.15 Million - $1.3 Million
-6,028 Reduced 9.04%
60,639 $12.9 Million
Q3 2023

Nov 15, 2023

SELL
$191.51 - $216.16 $1.15 Million - $1.3 Million
-6,028 Reduced 9.04%
60,639 $12.9 Million
Q2 2023

Dec 19, 2023

SELL
$187.64 - $206.25 $781,708 - $859,237
-4,166 Reduced 5.88%
66,667 $12.8 Million
Q2 2023

Aug 15, 2023

SELL
$187.64 - $206.25 $781,708 - $859,237
-4,166 Reduced 5.88%
66,667 $12.8 Million
Q1 2023

Dec 19, 2023

SELL
$127.59 - $203.08 $540,726 - $860,653
-4,238 Reduced 5.65%
70,833 $14.3 Million
Q1 2023

May 15, 2023

SELL
$127.59 - $203.08 $540,726 - $860,653
-4,238 Reduced 5.65%
70,833 $14.3 Million
Q4 2022

Dec 19, 2023

BUY
$117.37 - $139.17 $1.69 Million - $2.01 Million
14,432 Added 23.8%
75,071 $9.65 Million
Q4 2022

Feb 15, 2023

SELL
$117.37 - $139.17 $413,729 - $490,574
-3,525 Reduced 4.48%
75,071 $9.65 Million
Q3 2022

Nov 15, 2022

BUY
$135.27 - $180.11 $1.44 Million - $1.92 Million
10,640 Added 15.66%
78,596 $10.8 Million
Q2 2022

Aug 15, 2022

SELL
$108.81 - $179.33 $256,900 - $423,398
-2,361 Reduced 3.36%
67,956 $12 Million
Q1 2022

May 16, 2022

SELL
$119.61 - $157.85 $167,932 - $221,621
-1,404 Reduced 1.96%
70,317 $10.1 Million
Q4 2021

Feb 15, 2022

SELL
$142.57 - $190.86 $395,916 - $530,018
-2,777 Reduced 3.73%
71,721 $11.1 Million
Q3 2021

Nov 15, 2021

SELL
$142.45 - $169.82 $238,746 - $284,618
-1,676 Reduced 2.2%
74,498 $12.7 Million
Q2 2021

Aug 16, 2021

BUY
$135.08 - $161.1 $1.19 Million - $1.42 Million
8,833 Added 13.12%
76,174 $12 Million
Q1 2021

May 14, 2021

BUY
$137.51 - $190.8 $591,980 - $821,394
4,305 Added 6.83%
67,341 $9.35 Million
Q4 2020

Feb 12, 2021

BUY
$164.63 - $211.93 $2.31 Million - $2.97 Million
14,015 Added 28.59%
63,036 $11 Million
Q3 2020

Nov 16, 2020

BUY
$145.95 - $195.69 $7.15 Million - $9.59 Million
49,021 New
49,021 $9.59 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.